Find related topics. | Discover entities. | See connections. | Build a topical map.
Building topical map: Starting…
Eroxon: History, Regions & Companies
Eroxon (development code MED3000) is an over-the-counter topical gel used as a treatment for erectile dysfunction (ED). Its manufacturer is Futura Medical. The gel is regulated as a medical device and not as a drug, because its mode of action is a physical one and it doesn't have an active pharmaceutical ingredient. In clinical trials, about 60% of men…
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
More settings
Eroxon topic overview
The analysis highlights History, Regions and Companies as prominent areas in the source structure around Eroxon.
Related topics
52
Source areas
8
Connected nodes
60
Extracted relationships
99
Concept neighborhoods
23
Bridge connections
60
What this topic covers Research coverage
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Overview · 11 topics
Mechanism of action · 10 topics
Development · 8 topics
Composition · 7 topics
Reception · 6 topics
Commercialisation · 5 topics
Clinical trials · 3 topics
Regulatory history · 2 topics
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
Key facts & relationships
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Available
Europe, United States, Latin America, Middle East
Current supplier
Cooper Consumer Health (Europe); Market Performance Group (United States)
Inception
April 2021; 5 years ago (2021-04) (CE mark)
Inventor
Futura Medical
Manufacturer
Futura Medical
Models made
Eroxon, Eroxon Intense
Explore all related topics Closing gaps
A structured outline of related entities, concepts and subtopics. Open any item to build a new map centered on it.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
How Eroxon connects Entity context
Entity context groups extracted connections by relationship type. Counts show recurrence in the analyzed source; the examples are research signals, not claims about importance.
The extracted context around Eroxon shows recurring relationship patterns in the source. For example, Eroxon → American, April, Belgium, Boots, Cooper Consumer Health, CVS Pharmacy, France, Futura, Haleon, In June, It, Italy, July, Latin America, Market Performance Group, Middle East, October, Portugal, September, Spain Another extracted example is Eroxon → American, American Urological Association, Arthur Burnett, Cleveland Clinic, FDA, In, Johns Hopkins University, Korean, Men's Health, News, NYU Langone Health, Oral PDE5, Scott Lundy, Se Young Choi, Seth Cohen, Several, The, World Journal, Writing. Use these groups to spot repeated connection types before inspecting the individual relationships.
Eroxon
Top relations
related to Commercialisation· 25
Eroxon → American, April, Belgium, Boots, Cooper Consumer Health, CVS Pharmacy, France, Futura, Haleon, In June, It, Italy, July, Latin America, Market Performance Group, Middle East, October, Portugal, September, Spain
related to Reception· 19
Eroxon → American, American Urological Association, Arthur Burnett, Cleveland Clinic, FDA, In, Johns Hopkins University, Korean, Men's Health, News, NYU Langone Health, Oral PDE5, Scott Lundy, Se Young Choi, Seth Cohen, Several, The, World Journal, Writing
related to Development· 18
Eroxon → British, Erectile Function, FM57, Futura, Futura Medical, GTN, Guildford, II, IIEF, III, In, International Index, London Stock Exchange AIM, MED2005, MED3000, Sexual Medicine, The, The Journal
related to history· 17
Eroxon → April, CE, Class II, Class IIb, De Novo, DEN220078, Europe, FDA, FM57, Futura, In, June, October, The, Three, UKCA, United Kingdom
related to Composition· 4
Eroxon → DermaSys, Futura Medical, It, None
related to Related products· 4
Eroxon → CE, Eroxon Intense, Futura Medical, UKCA
Available· 1
Eroxon → Europe, United States, Latin America, Middle East
Current supplier· 1
Eroxon → Cooper Consumer Health (Europe); Market Performance Group (United States)
Inception· 1
Eroxon → April 2021; 5 years ago (2021-04) (CE mark)
Inventor· 1
Eroxon → Futura Medical
Important terminology
Frequent words and multi-word phrases across the lead, headings, infobox and body. Useful for terminology coverage.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
Relationships are represented as Subject → Predicate → Object triples. Confidence describes extraction strength, not the real-world importance of a relationship; lower-confidence rows may be contextual rather than explicit.
TTTA extracted 99 structured relationships around Eroxon. Examples in this analysis include Eroxon → Available → Europe, United States, Latin America, Middle East and Eroxon → Current supplier → Cooper Consumer Health (Europe); Market Performance Group (United States). The table shows each extracted connection, where it came from and its confidence.
Subject
Predicate
Object
Confidence
Src
Eroxon
Available
Europe, United States, Latin America, Middle East
1.00
infobox
Eroxon
Current supplier
Cooper Consumer Health (Europe); Market Performance Group (United States)
1.00
infobox
Eroxon
Inception
April 2021; 5 years ago (2021-04) (CE mark)
1.00
infobox
Eroxon
Inventor
Futura Medical
1.00
infobox
Eroxon
Manufacturer
Futura Medical
1.00
infobox
Eroxon
Models made
Eroxon, Eroxon Intense
1.00
infobox
Eroxon
Type
Medical device (topical gel)
1.00
infobox
Eroxon
Website
www.eroxon.com
1.00
infobox
Eroxon
is a
first topical ED treatment sold over the counter in the United States
0.90
text
sildenafil
instance of
The end point resembles the one reached by phosphodiesterase type 5 inhibitors
0.80
text
tadalafil
instance of
The end point resembles the one reached by phosphodiesterase type 5 inhibitors
0.80
text
though by a physical route
instance of
The end point resembles the one reached by phosphodiesterase type 5 inhibitors
0.80
text
No triples extracted yet.
Related concept clusters Concept neighborhoods
Concept neighborhoods group terms that sit near one another in the extracted graph. They are useful for discovering adjacent language and context, but proximity does not by itself imply a factual relationship.
The concept neighborhoods around Eroxon bring nearby vocabulary together. In this analysis, examples include United, Ce and Treatment. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Eroxon
United
Ce
Treatment
Topical
Sold
Medical
Ed
Mark
Europe
Device
Fda
States
eroxon
United
Ce
Treatment
Topical
Sold
Medical
Ed
Mark
Europe
Device
Fda
States
gel
Sold
American
Men
Medical
Trial
America
East
Latin
Middle
Ce
Europe
Trials
medical device
Medical
Erection
Topical
Sold
Ce
Group
America
Drug
East
Eroxon
Latin
Mark
united states
States
United
Europe
America
East
Latin
Middle
Eroxon
Sold
Mark
Ce
Topical
united kingdom
States
Europe
Eroxon
Sold
America
East
Latin
Mark
Middle
Ce
Topical
Futura
ce mark
Mark
Europe
Eroxon
United
America
East
Latin
Middle
Medical
Reached
Trials
Fm57
europe
Mark
Ce
America
East
Latin
Middle
United
States
Sold
Reached
Trials
Gel
Connections between topic areas Semantic bridges
Semantic bridges connect parts of the graph that would otherwise be more separate. A bridge is a structural signal in this analysis, not a claim that the two topic areas are equivalent.
For Eroxon, one of the stronger structural bridges in this analysis connects Eroxon with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
Number of nodes, edges, triples, density and central hubs. Use it to gauge the size and connectivity of the map.
Eroxon
Nodes61
Edges60
Triples99
Avg. degree1.97
Density0.032787
Components1
Source & methodology
TTTA analyzes the structure around Eroxon to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Regions & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
